FB Pixel no scriptChinese officials from 7 agencies join Didi investigation | KrASIA

Chinese officials from 7 agencies join Didi investigation

Written by Nikkei Asia Published on   2 mins read

Tax, transport, and competition regulators part of on-site security probe.

China’s cybersecurity agency said on Friday that a team of officials from seven national regulators was being dispatched for an on-site inspection of the operations of ride-hailing company Didi Global.

In addition to the Cyberspace Administration of China, other bodies represented in the group include the State Administration for Market Regulation, the ministries of public security, state security, transport and natural resources, and the State Administration of Taxation.

Earlier this month, the CAC ordered mobile app stores to remove 26 of Didi’s programs, including its main ride-hailing app, and blocked it from signing up new customers just days after the Beijing-based company’s USD 4.4 billion initial public offering on the New York Stock Exchange. The agency said Didi had wrongly collected and mishandled personal data from its customers.

“We sincerely thank the authorities for guiding Didi to manage our risks,” Didi said in a statement on July 4. “We will resolutely rectify the problems and improve our risk-prevention awareness and technical capabilities.”

Read more: China’s cyberspace watchdog is shaking US capital markets

uptake newsletter

The company did not immediately respond on Friday to requests for comment on the expanded investigation.

Didi shares closed on Thursday at USD 12.36 compared with their IPO price of USD 14.

After absorbing its biggest rivals over the past several years, Didi controls a large majority of China’s ride-sharing market. Its shareholders include Apple, SoftBank Vision Fund, Uber Technologies and Tencent Holdings.

In the aftermath of the CAC’s moves against Didi, the agency announced that any companies holding data on more than 1 million customers would need its approval before seeking an offshore IPO.

Since then, several Chinese companies have put on hold or canceled plans for New York listings, including Alibaba Health Information-backed medical data group LinkDoc Technology.

This article first appeared on Nikkei Asia. It’s republished here as part of 36Kr’s ongoing partnership with Nikkei.


Auto loading next article...